NCT07026227View on ClinicalTrials.gov

Effect of Xuebijing in Alleviating Acute Kidney Injury After High-voltage Electrical Burns

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

August 20, 2023

Study Completion Date

November 30, 2023

Conditions
Acute Kidney Injury
Interventions
DRUG

Xuebijing Injection

Xuebijing injection (Tianjin Hongri Pharmaceutical Co., Ltd., National Drug Standard Z20040033).

PROCEDURE

Conventional Treatment for High-Voltage Electrical Burns and AKI

Standard multidisciplinary care including general burn assessment, wound management (cleaning, debridement, dressings), fluid resuscitation as per burn protocols, management of electrolyte imbalances

Trial Locations (1)

050000

First Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

The First Hospital of Hebei Medical University

OTHER